Alphamab Oncology (HKG:9966)
8.49
+0.48 (5.99%)
Mar 10, 2026, 11:59 AM HKT
39.87% (1Y)
| Market Cap | 7.76B |
| Revenue (ttm) | 861.24M |
| Net Income (ttm) | 255.11M |
| Shares Out | 968.57M |
| EPS (ttm) | 0.26 |
| PE Ratio | 30.94 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 550,000 |
| Average Volume | 1,065,775 |
| Open | 8.10 |
| Previous Close | 8.01 |
| Day's Range | 8.10 - 8.55 |
| 52-Week Range | 4.86 - 15.75 |
| Beta | 0.40 |
| RSI | 46.92 |
| Earnings Date | Mar 27, 2026 |